Pfizer Building Structural Scare Unlikely to Slow New York's Office-to-Residential Conversion Push

Our take

While this story is set in New York, it carries real lessons for South African property stakeholders — particularly in Johannesburg and Cape Town's CBD, where office vacancies have climbed sharply post-pandemic and adaptive reuse conversations are gaining traction. The Pfizer incident underscores a critical point: converting ageing commercial stock into residential units is technically demanding and carries structural risks that go well beyond a standard architectural survey. For SA developers eyeing vacant office blocks in areas like Sandton, Braamfontein, or the Cape Town foreshore, this is a timely reminder that due diligence — including independent load testing and third-party structural modelling — is non-negotiable, not a cost-saving opportunity. For prospective buyers or tenants considering off-plan units in conversion projects, it reinforces the importance of asking hard questions about engineering sign-off and developer track record before committing. Local regulators and municipal building departments could also draw from New York's experience to tighten review protocols proactively, rather than reactively. South Africa's housing shortage is acute; adaptive reuse remains a viable part of the solution — but only when executed with rigorous oversight.